The Wingless (Wg)/Wnt signal transduction pathway controls fundamental processes during animal development. Deregulation of the Wg/Wnt pathway has been causally linked to several forms of cancer, most notably to colorectal cancer. In response to Wg/Wnt signaling, Armadillo/b-catenin associates in the nucleus with DNA bound TCF and several co-factors, among them Legless/BCL9, which provides a link to Pygopus. Recently, the second vertebrate homologue of Legless, BCL9-2 (or B9L), was characterized and proposed to mediate Wnt signaling in a Pygopus-independent manner, by binding to a Tyrosine-142-phosphorylated form of b-catenin. Here we examine the role of Tyrosine-142 phosphorylation in several assays and find that it is neither important for the recruitment of BCL9-2, nor for the transcriptional activity of b-catenin in cultured mammalian cells, nor in Drosophila for Wg signaling activity in vivo. Furthermore, we demonstrate that BCL9-2 can functionally replace Lgs both in cultured cells as well as in vivo and that this rescue activity depends on the ability of BCL9-2 to bind Pygo. Our results do not show a significant functional difference between BCL9-2 and BCL9 but rather suggest that the two proteins represent evolutionary duplicates of Legless, which have acquired distinct expression patterns while acting in a largely redundant manner.
Introduction
The Armadillo (Arm) protein in Drosophila and its vertebrate homolog b-catenin have a dual function. On the one hand they bind a-catenin and the cytoplasmic tail of E-cadherin, thereby forming an integral part of adherens junctions Yamada et al., 2005) . On the other hand they function as the key effector protein of the Wingless (Wg)/ Wnt signaling pathway (reviewed in Bienz and Clevers, 2003; Moon et al., 2002; Städeli et al., 2006; Tolwinski and Wieschaus, 2004) . In the absence of the Wg/Wnt ligand Arm/b-catenin that is not part of adherens junctions is degraded. This degradation is initiated by the binding of Arm/b-catenin to its destruction complex consisting of Adenomatous Polyposis Coli (APC), Axin, Casein Kinase I and GSK-3b. Following phosophorylation by the two latter components, Arm/bcatenin is ubiquitinated and targeted for proteasome-mediated degradation (Aberle et al., 1997; Behrens et al., 1998; Ikeda et al., 1998; Kishida et al., 1998; Liu et al., 2002) . The signaling pathway is activated by binding of Wg/Wnt ligand to the receptor Frizzled, which together with Arrow/LRP signals through Dishevelled to inhibit the formation of the destruction complex. As a consequence, Arm/b-catenin accumulates in the cytoplasm, enters the nucleus, and associates with members of the TCF/Lef family of DNA binding transcription factors (Behrens et al., 1996; Brunner et al., 1997; Huber et al., 1996; Molenaar et al., 1996; Riese et al., 1997; van de Wetering et al., 1997) . In the nucleus b-catenin interacts with additional proteins such as CBP/p300, Brg-1, MED12, Parafibromin and Legless (Lgs)/BCL9 (Barker et al., 2001; Hecht et al., 2000; Kim et al., 2006; Kramps et al., 2002; Takemaru and Moon, 2000; Mosimann et al., 2006) . The latter can also bind to Pygopus (Pygo), and in this way recruit Pygo to the b-catenin-TCF complex (Kramps et al., 2002; Thompson, 2004) . A chimeric Pygo-Lgs protein in which the Lgs interaction domain of Pygo (PHD) has been replaced by the b-catenin interaction domain of Lgs (HD2) can rescue both lgs and pygo mutant animals suggesting that the primary function of Lgs is the recruitment of Pygo to Arm/b-catenin (Kramps et al., 2002; Thompson, 2004) . While Pygo, like Lgs, is necessary for Wg signaling, the molecular role of Pygo in the transcription of Wg/Wnt target genes remains largely unknown (Belenkaya et al., 2002; Kramps et al., 2002; Parker et al., 2002; Städeli and Basler, 2005; Thompson et al., 2002; Thompson, 2004) .
Two recent studies describe the analysis of the second mammalian Lgs ortholog, BCL9-2 (or BCL9-like, B9L). This protein was discovered independently in two different yeast two-hybrid screens designed to identify binding partners of b-catenin (Adachi et al., 2004; Brembeck et al., 2004) . The binding of BCL9-2 to b-catenin was reported to depend on the phosphorylation of tyrosine 142 (Y142) of b-catenin, since mutating this amino acid, or preventing its phosphorylation, abrogated the binding (Brembeck et al., 2004) . BCL9-2 was suggested to differ further from BCL9 in its ability to transcriptionally activate target genes in a Pygo-independent manner (Adachi et al., 2004; Brembeck et al., 2004) .
Here we report our findings showing that Y142 of b-catenin/Arm and its phosphorylation are not important for the binding to Lgs, BCL9 or BCL9-2. Indeed, just like for Lgs and BCL9, the interaction of BCL9-2 with b-catenin depends on residue D164 of b-catenin/Arm. We demonstrate that Y142 of Arm/b-catenin is critical neither for Wg/Wnt signaling in mammalian and Drosophila tissue culture cells, nor for Wg signaling in vivo. In addition BCL9-2 can functionally replace Lgs in Drosophila, but only when able to recruit Pygo. Finally, we show that BCL9-2 interacts with Pygo in mammalian cells and is part of a larger complex that contains b-catenin as well as Parafibromin. Taken together our results indicate that BCL9-2 and BCL9 differ less than previously proposed, and suggest instead that potential differences in their genetic requirement stem from regulatory rather than functional divergence.
Results

Phosphorylation of tyrosine 142 of Arm/b-catenin is not necessary for BCL9-2 binding
We previously identified two amino acids in Arm/b-catenin, D162 and D164 that are necessary for Lgs/BCL9 binding (Hoffmans and Basler, 2004) . A recent report put forth a model in which residue Y142 of b-catenin needs to be phosporylated in order to bind the BCL9 homolog BCL9-2 (Brembeck et al., 2004) . We therefore wanted to know if D164 is also important for BCL9-2 binding and if Y142 has an influence on Lgs/BCL9 binding. In conjunction with BCL9 or BCL9-2, various mutant forms of b-catenin were tested in a quantitative yeast two-hybrid assay. As a control a-catenin was used, which is known to depend on Y142 for binding to b-catenin (Aberle et al., 1996; Pokutta and Weis, 2000) . Mutating aspartic acid 164 of b-catenin to alanine (D164A) abolished the binding of b-catenin to both BCL9 and BCL9-2. Altering tyrosine Y142 of b-catenin (to alanine, Y142A) did not affect binding of b-catenin to BCL9 but did abolish binding to a-catenin (Fig. 1A and Aberle et al., 1996; Pokutta and Weis, 2000) . Surprisingly however, this alteration, Y142A, did not exhibit decreased binding to BCL9-2 (Fig. 1A) Weis, 2000). By changing Y142 to phenylalanine (Y142F) the necessity of the free hydroxyl group of Y142 was determined. Y142F had no significant effect on the binding of bcatenin to either BCL9, BCL9-2 or a-catenin ( Fig. 1A and Aberle et al., 1996) . In a converse experiment Y142 was replaced by either aspartic or glutamic acid (Y142D and Y142E, respectively), mimicking phosphorylation of the Y142 hydroxyl group. This alteration had no effect on the binding of b-catenin to BCL9, but increased somewhat the binding to BCL9-2, and abolished binding to a-catenin. Corresponding mutations were introduced into Arm and assayed for their effect on the binding to Lgs and BCL9-2, as well as to the Drosophila homolog of a-catenin (Fig. 1B) . The results were similar to those described above for the mammalian components except that Drosophila a-catenin bound better to Arm-Y142A than a-catenin to b-catenin-Y142A. Together these binding studies suggest that the interactions of b-catenin/Arm with BCL9, BCL9-2 or Lgs all require residue D164, but not Y142, which is, however, important for binding to a-catenin.
Signaling capacity of full-length Arm does not depend on tyrosine 142
To investigate if a mutant form of Arm containing the Y142A alteration has impaired signaling activity in Drosophila we tested if Arm-Y142A can substitute for wildtype Arm in vivo by performing a rescue assay. For this purpose we used a tub-Arm-Y142A transgene, which expresses the Y142A mutant under the control of the tubulina1 promoter, in conjunction with the arm 2a9 allele, which exhibits a frameshift mutation in Arm repeat 3 and is presumed to be null (Peifer and Wieschaus, 1990) . Hemizygous arm 2a9 males die as embryos but can be rescued to adults by a tub-Arm-wt transgene without any obvious phenotypes (Table 1 and Hoffmans and Basler, 2004) . In contrast, the previously described tub-Arm-D164A transgene (Hoffmans and Basler, 2004) cannot rescue arm 2a9 mutants beyond embryonic or early larval stages (Table  1) . The tub-Arm-Y142A transgene, however, can rescue arm 2a9 mutants all the way to adulthood, although not as efficiently as tub-Arm-wt. The rescued males do not show any obvious phenotypes (Table 1) .
Explanations for the different efficiencies by which Armwt and Arm-Y142A rescue arm null mutants could be either that Arm-Y142A is partially impaired in Wg signaling or in its cell adhesion function (or both). To discriminate between these possibilities we sought to use an arm allele that is defective in Wg signaling but not adhesion function. arm S7X-2 is such an allele (containing a single amino acid substitution, R474H; Brunner, 1997); arm S7X-2 hemizygous males die as pupae. This pupal lethality can be overcome by expression of Arm-wt or Arm-Y142A, but not by Arm-D164A (Table 1 ). The rescue of hemizygous arm S7X-2 males by Arm-wt or Arm-Y142A is equally efficient, suggesting that the Y142A form of Arm is primarily impaired in cell-adhesion function and not Wg signaling.
To further compare the signaling potential of Arm-wt and Arm-Y142A in a more quantitative assay a Drosophila S2 cell model was used. The wf-luciferase reporter is activated 20-fold upon stimulation with Wg (Hoffmans et al., 2005; Städeli and Basler, 2005) . RNA interference (RNAi) directed against the 3 0 UTR of arm resulted in a severe knock down of reporter gene activity (Fig. 2) . This reduction in activity can be rescued equally well by the transfection of expression constructs for Arm-wt or Arm-Y142A, Females heterozygous for arm (arm 2a9 or arm S7X-2 ) were crossed with males carrying different tubulina1-promoter-driven rescue constructs. The percentage of rescued male progeny containing both the mutant arm allele and the tubulina1-driven rescue construct are shown. n indicates the male progeny that contain the tubulina1-driven rescue construct but inherited the wild-type arm allele from the balancer chromosome instead of the mutant arm allele and therefore corresponds to the expected number (100% rescue) of arm mutant males with the tubulina1-driven rescue construct. 
Control
Arm-wt Arm-Y142A Arm-D164A Fig. 2 . The signaling potential of Arm-Y142A is comparable to that of Arm-wt. In S2 cells Arm-wt and Arm-Y142A could rescue Arm 3 0 UTR RNAi to a similar extent as measured by the wf-luciferase reporter. However the Arm-D164A protein could not rescue signaling. To activate the pathway, cells were cocultured with Wg-secreting cells (van Leeuwen et al., 1994) , which resulted in a 20-fold stimulation of the wf-luciferase (data not shown). The rescue activity of Arm-wt, Arm-Y142A and Arm-D164A is represented relative to the respective GFP RNAi negative control. Error bars represent standard deviations of triplicates. in which the 3 0 UTR of arm is replaced by the 3 0 UTR of tubulina1. In contrast, as expected, Arm-D164A (with the tubulina1 3 0 UTR) failed to rescue signaling activity. We can conclude from this that Arm-Y142A has the same signaling capacity as Arm-wt. Together with the experiments described above these results suggest that Y142 phosphorylation is not necessary for Wg signaling in Drosophila.
2.3. Constitutive signaling activity of Arm S10 does not depend on tyrosine 142
The results from the binding and rescue experiments suggested that residue Y142 is necessary for the cell adhesion function of Arm but not for its signaling activity. To further confirm this we thus wanted to test the Y142A mutation in an in vivo signaling assay that is not complicated by adhesion dependence. b-catenin/Arm mutants that have N-terminal truncations and lose the GSK-3b phosphorylation sites are resistant to degradation and hence can over-activate the Wg signaling pathway (Pai et al., 1997) . One such constitutively active form is Arm S10 , which has an N-terminal in-frame deletion but can still bind a-catenin. Ubiquitous expression of an Arm S10 -wt transgene (driven by daughterless-Gal4) suppresses denticle formation in the embryo and results in a naked cuticle ( Fig. 3B and Pai et al., 1997; Hoffmans and Basler, 2004) . This Wg gain of function phenotype is completely abolished if Arm S10 contains the D164A mutation, which prevents binding to Lgs (Arm S10 -D164A, see Fig. 3D and Hoffmans and Basler, 2004) . In contrast, the Y142A mutation shows a similar gain of signaling activity as Arm S10 -wt (Arm S10 -Y142A, see Fig. 3C ). Thus, constitutive Arm S10 depends on residue D164 but not Y142 for its function. We take this as further proof that Y142 is not essential for the transcriptional output of Arm in vivo.
Tyrosine 142 is also dispensable for the transcriptional activity of b-catenin
The experiments presented above suggest that Y142 of Arm is not necessary for Wg signaling in Drosophila. In order to test the relevance of this tyrosine residue for the transcriptional output of b-catenin, different forms of constitutively active b-catenin (S33Y) fused to the DNA binding domain of Gal4 (G4DBD-S33Y) were compared using UAS-luciferase as a read out (Hoffmans et al., 2005) . In human embryonic kidney 293 (HEK293) cells, which express low levels of BCL9-2 (Adachi et al., 2004; Brembeck et al., 2004) , addition of G4DBD-S33Y-wt caused strong transcriptional activation of the reporter. The S33Y-D164A form, which cannot bind BCL9 and BCL9-2, is much less active. Consistent with the Drosophila results the Y142A mutant is as active as the wild-type form. Moreover, mimicking phosphorylation by changing Y142 to glutamic or aspartic acid did not increase transcriptional activity (Figs. 4A,B) . Similar results were obtained in SW480 cells (Figs. 4C,D) , which have high levels of BCL9-2 (Adachi et al., 2004) . Together this suggests that Y142 of b-catenin is not essential for Wnt target gene activation in mammalian tissue culture cells.
Both BCL9-2 and BCL9 can functionally replace Lgs
It was previously reported that BCL9-2, in contrast to BCL9 and Lgs, does not depend on Pygo binding for its function as a transcriptional activator (Adachi et al., 2004; Brembeck et al., 2004) . To further explore the possible Pygo-independence of BCL9-2 we examined the significance of the Pygo-BCL9-2 interaction for Wg signaling. First, we asked whether BCL9-2 can functionally replace Lgs in tissue culture cells. The rescue activities of BCL9 and BCL9-2 were assayed by the wf-luciferase assay (see above) following RNAi-mediated knock-down of lgs (Fig. 5A ). BCL9 very efficiently rescued the drop in signaling activity caused by the absence of Lgs (Fig. 5A) ; this effect of BCL9 is dependent on its ability to bind Pygo since a mutant form of BCL9 that cannot bind Pygo (BCL9DHD1, Kramps et al., 2002) cannot rescue knock-down of lgs. The BCL9-2 protein was also able to rescue signaling activity although not to the same extent as BCL9 (Fig. 5A ). This activity of BCL9-2 does not depend on the nuclear localization signal (NLS), since BCL9-2 with a deleted NLS (BCL9-2D138-173, Brembeck et al., 2004 ) is as active as full length BCL9-2. However, importantly, the ability of BCL9-2 to replace Lgs is dependent on Pygo binding, because a mutant form of BCL9-2 that lacks HD1 (BCL9-2DPyBD, Brembeck et al., 2004 ) not only fails to bind Pygo (Fig. 5B) but also fails to rescue signaling activity (Fig. 5A) .
BCL9 has been shown to be able to rescue viability and limb pattern defects of lgs 17E /lgs 21L animals, which normally die as pharate adults (Kramps et al., 2002) . We applied the same assay to BCL9-2 and generated transgenes that expressed either BCL9-2 or BCL9-2DPyBD under the control of the ubiquitous tubulina1 (G4DBD-S33Y ). This caused a robust activation of the UAS-luciferase reporter. However, the D164A form, which is mutant for BCL9 and BCL9-2 binding, showed strongly reduced activity. The mutants for Y142 showed a similar activity as the wild-type form. (B) Western blot of HEK293 cell lysates demonstrating that all b-catenin forms are expressed at similar levels. The G4DBD-S33Y-D164A protein seems to be expressed at a slightly lower level in this particular blot. We do not think that this influenced the UAS-luciferase reporter assay in (A). In other experiments G4DBD-S33Y-D164A was expressed at similar levels compared to the other b-catenin forms and showed identical UAS-luciferase reporter results (see (C-D) and Hoffmans et al., 2005) 
. (C) SW480 cells were transfected as in (A). The outcome of the SW480 cell experiment was identical to that in (A). (D)
Western blot of SW480 cell lysates showed that all G4DBD-S33Y proteins were expressed equally well. Error bars represent standard deviations of triplicates.
promoter. BCL9-2 rescued lgs 17E /lgs 21L animals without any obvious phenotype. BCL9-2DPyBD, however, could not rescue lgs mutant animals (data not shown). These results suggest that BCL9-2, like BCL9, is a functional homologue of Lgs and that BCL9-2, like BCL9, depends on Pygo for its function.
BCL9-2 forms a complex with Pygo, b-catenin and Parafibromin
If BCL9-2 is a functional homolog of Lgs, it should also, like Lgs, bind Pygo in vivo (Thompson, 2004) . This assumption was confirmed by co-immunoprecipitation experiments in HEK293T cells (Fig. 5C ). Since it was recently shown for BCL9 that it forms a complex with b-catenin and Parafibromin in LiCl-stimulated cells (Mosimann et al., 2006) , we also wanted to test if this is the case for BCL9-2. Indeed, antibodies against Parafibromin co-precipitate BCL9-2, indicating that BCL9 and BCL9-2 form similar complexes in the nucleus of Wnt-transducing cells.
Discussion
Wg/Wnt signals play pivotal roles in developmental processes by regulating the transcription of genes in target cells. Arm/b-catenin, the effector component of the pathway, is post-transcriptionally upregulated and accumulates in the cytoplasm and nucleus. There it associates with the DNA-binding protein TCF/Lef and several adaptor and co-activator proteins. One such adaptor is Lgs/BCL9, which enables Arm/b-catenin to recruit Pygo. While there is only one gene encoding this adaptor in Drosophila (i.e. lgs), vertebrate genomes contain two such genes (BCL9 and BCL9-2, Kramps et al., 2002) . Two previous studies have ascribed unique properties and functions to BCL9 and BCL9-2 (Adachi et al., 2004; Brembeck et al., 2004) , namely that BCL9-2 functions independently of Pygo and depends on phosphorylation of tyrosine 142 of b-catenin to be able to interact with it. We initially sought to determine if residue D164 of b-catenin, crucial for BCL9 binding, was also important for BCL9-2 binding. This study was extended to compare the signaling properties of the two proteins in other assays available to us. Although the repertoire of these assays has some limitations (e.g. a deficit in vertebrate genetics, see below), our experiments did not reveal any significant functional differences between the two human homologs. Instead, it appears that BCL9 and BCL9-2 represent evolutionary duplicates of Lgs that can function in a largely redundant manner.
We first provided evidence that binding of BCL9, BCL9-2 and Lgs to Arm/b-catenin does not depend on tyrosine residue 142 of Arm/b-catenin. Single amino acid substitutions of Y142 had no effect on the transcriptional activity of Arm/bcatenin, neither in vivo nor in tissue culture cells. We went on to show that BCL9-2 can functionally replace Lgs in vivo and in cultured cells, and that this activity of BCL9-2 depends on its ability to bind Pygo. Finally, we found that BCL9 and BCL9-2 can interact with the same partners and form similar complexes in the nucleus of stimulated cells.
It was previously reported that BCL9-2 only interacted efficiently with b-catenin if the latter is phosphorylated on tyrosine 142. In the absence of tyrosine kinase activity no interaction of the two proteins was detected in a special yeast two-hybrid system (Brembeck et al., 2004) . Furthermore, a mutation of b-catenin's tyrosine 142 to alanine abrogated binding to BCL9-2 (Brembeck et al., 2004) . In contrast, our binding studies indicate that the binding of Arm/b-catenin to BCL9-2 does not dependent on Y142 phosphorylation. In agreement with our results, BCL9-2 was also identified as a b-catenin binding partner in a standard yeast two-hybrid system that lacks protein tyrosine kinase activity (Adachi et al., 2004) . One explanation to account for the discrepancy between the two results may be attributed to the use of different lengths of b-catenin proteins in the binding assays. While full-length b-catenin was used in the present study, Brembeck et al. (2004) used a shortened protein containing only the Armadillo repeats, and Adachi et al. (2004) used a form that in addition to the Arm repeats contained small parts of the N-and C-termini.
The arm 2a9 allele is the strongest arm allele available, has a frameshift mutation in Arm repeat 3 and fails to provide both adhesion function as well as Wg transduction activity (Peifer et al., 1993; Peifer and Wieschaus, 1990) . A transgene encoding Arm-Y142A was able to rescue arm 2a9 males, but less efficiently as the control transgene encoding wild-type Arm. We attributed this difference to a slight deficit in adhesion function, a hypothesis supported by the observations that Arm-Y142A exhibited reduced a-catenin binding while it fully rescued a signaling-defective but adhesion-competent allele of arm (arm S7X-2 ). Furthermore, no difference could be observed in Wg signaling activity when Arm-Y142A and Arm-wt were interrogated in a quantitative signaling assay in S2 cells. Together, these experiments indicate that the transduction of the Wg signal through Arm does not depend on residue Y142.
To compare the BCL9-2 and BCL9 proteins we tested their ability to substitute for Lgs in Wg signaling. Both human homologs were able to provide Lgs signaling function. Interestingly, both Adachi et al. (2004) and Brembeck et al. (2004) reported that the signaling activity of BCL9-2 does not depend on Pygo binding, but on the C-terminus of BCL9-2. However, in our replacement assays in Drosophila, we found that both human proteins depended equally on their Pygo-binding domain (HD1). At the amino acid level BCL9 and BCL9-2 share three homologous regions of 20-30 amino acids in their C-termini. These short clusters are not found in Lgs; furthermore, we had previously found that the C-terminal half of Lgs is dispensable for Lgs function in Drosophila (Kramps et al., 2002) . Future studies will have to clarify a potential contribution of these C-termini to Wnt signaling in vertebrates. The conservation of these clusters in both BCL9 and BCL9-2 suggests that whatever the function of the C-terminus it is conserved between the two proteins. A dendrogram is shown which represents the relationships between homologues of the Lgs proteins in different species on the basis of an alignment of full length protein sequences. The dendogram shows that most likely there was a duplication that created the two BCL9 forms in vertebrates. Such a model is consistent with our data in which we do not see a difference in BCL9 and BCL9-2 function. We therefore propose that BCL9 and BCL9-2 have similar functions but may be differently expressed. The dendogram was generated using the ClustalW alignment program in MacVector. We have not been able to identify a C. elegans homologue of Lgs; indeed, none of the three b-catenin homologues in C. elegans contains the DED motif we previously showed to be necessary for BCL9/Lgs binding in Drosophila, mouse, and human (Hoffmans and Basler, 2004) .
One approach that might shed light on this issue is to generate mice lacking BCL9 and BCL9-2 and see if the phenotypes of these animals can be rescued by a transgene ubiquitously expressing either only BCL9, BCL9-2 or Lgs. Less stringent signaling assays based on RNAi in cultured mammalian cells were uninformative, as the simultaneous addition of two siRNAs (against both bcl9 and bcl9-2) decreased their knock-down efficiency (not shown), complicating the interpretation of the results.
Phylogenetic sequence comparisons indicate that a relatively recent event of gene duplication created the two BCL9 forms in vertebrates (Fig. 6) . Our results here indicate that these proteins are essentially identical, at least regarding their interaction with b-catenin as well as regarding their capacity to transduce the Wg signal and to form higher order complexes containing b-catenin and Parafibromin. We thus suggest that the BCL9 proteins function in a largely redundant manner, as adaptor proteins for the recruitment of Pygo to the b-catenin-TCF complex.
Materials and methods
Plasmid constructs
Single amino acid mutations were introduced by site-directed mutagenesis (Quickchange, Stratagene) in mouse b-catenin (amino acids 1-781) and Arm (amino acids 38-806), which were cloned in pGAD424 (Clontech). Human BCL9 (amino acids 199-392), mouse a-catenin (amino acids 1-750), human BCL9-2 (amino acids 232-427), Lgs (amino acids 364-555), Pan (amino acids 1-129) and Drosophila a-catenin (amino acids 1-394) were cloned into pBTM116 (Bartel and Fields, 1997) . All constructs were verified by sequencing.
pcDNA3.1 (Invitrogen) or pPacPL (Koelle and Hogness, 1992) vectors were used for expression of cDNAs in mammalian cells or S2 cells, respectively.
b-catenin amino acid numbering was used for both b-catenin and Arm throughout the text. b-Catenin Y142 and D164 would correspond to Arm Y150 and D172.
dsRNA production
Templates for GFP, Lgs and Arm (3 0 UTR) dsRNA synthesis were generated by PCR using the following primers containing 5 0 T7 promoter tails: fGFP 5 0 T7CTTTTCACTGGAGTTGTCC, rGFP 5 0 T7ATCCATGC CATGTGTAATCC, product length: 0.68 kb; fLgs 5 0 T7GGCATGCGTCCACATGCC, rLgs 5 0 T7ATTTGTTGAC AAAGAACGTTG, product length: 0.58 kb; T7_Arm3 0 f 5 0 T7 ACAAGCCGAGCTAAGGGTAAG, T7_Arm3 0 r 5 0 T7CATATGAAGGGAAATGTACG, product length: 0.43 kb; dsRNA was then synthesized from these templates using the Ambion Megascript kit. For RNAi in S2 cells (Clemens et al., 2000) 1 lg of dsRNA was used per well (96 well plate).
Cell culture
S2 cell transfections were performed in 96 well plates using polyethylenimine (PEI, Polysciences, Inc) with a total of 500 ng of DNA per 3 wells (50 ng wf-luc, 100 ng actin5c-renilla, 50 ng tubulina1-dfrizzled2, 50 ng rescue constructs (BCL9 and 9.2) and 250 ng empty vector or 2,5 ng rescue constructs (Arm) and 300 ng empty vector; the control wells received 50 ng or 2,5 ng empty vector extra instead of rescue constructs). The Wg signaling pathway was induced 48 h after transfection by adding heat-shocked S2 cells stably transfected with a wg cDNA under the control of a heat-shock promoter (van Leeuwen et al., 1994) .
HEK293 and SW480 cell transfections were performed in 24 well plates using Lipofectamine (Invitrogen) with a total of 0.8 lg of DNA per 3 wells (300 ng UAS-luc, 100 ng pCMV-RL (Promega), 300 ng Gal4DBD constructs, 100 ng of empty vector).
Luciferase activities were determined after 72 h for S2 cells and after 48 h for HEK293 and SW480 cells using the Dual-Luciferase Assay System (Promega).
The tissue culture experiments have been performed at least three times.
Protein interaction studies
The yeast two-hybrid system was used as described in chapter 3 of Bartel and Fields (1997) . Interactions between proteins were measured using the quantitative 'Liquid Culture Assay Using ONPG as Substrate' (Clontech, Yeast Protocols Handbook, http://www.clontech.com/clontech/ Techinfo/manuals).
For immunoprecipitation experiments, 10 cm dishes seeded with HEK293 or HEK293T cells (2 · 10 6 ) were transfected with a total of 8 lg DNA (6 lg FLAG-BCL9-2 + 2 lg HA-Pygo2 or 4 lg FLAG-BCL9-2 + 4 lg empty vector) using Lipofetamine. In the case of the IP with Parafibromin, b-catenin was stabilized by the addition of LiCl (endconcentration 25 nM) 16 h before lysis. Cells were lysed in NP-40 lysis buffer (Rozenblatt-Rosen et al., 2005) 48 h after transfection, the lysates cleared by centrifugation and subsequently used for precipitation experiments (275 ll lysate, 30 ll Protein-A Sepharose (Amersham Biosciences), 1-2 lg antibody). After 2 h incubation at 4°C and 3· washing with NP-40 lysis buffer, pulldowns were analyzed on NuPAGE gels (Invitrogen).
Antibodies
The following antibodies were used: mouse anti-FLAG (M2, Sigma), mouse anti-Tubulin (B-5-1-2, Sigma), rabbit anti-HA (SC-805, Santa Cruz), rabbit anti-Gal4DBD (SC-577, Santa Cruz) and rabbit anti-Parafibromin (BL649, Bethyl Labs).
Transgenes
For embryonic experiments arm transgenes were expressed from UASconstructs under control of the daughterless-Gal4 driver (Wodarz et al., 1995) . Several independent lines of arm S10 -wt, arm S10 -Y142A and arm S10 -D164A transgenes were established and tested. For rescue experiments full-length arm transgenes were driven by the tubulina1 (tub) promoter (Basler and Struhl, 1994) . All arm coding regions used contain a c-Myc epitope in their C-terminal region at the same position as in the original arm S10 (Pai et al., 1997) .
